Tg Therapeutics's 15min chart triggers KDJ Golden Cross, bullish Marubozu signal.
ByAinvest
Thursday, Aug 28, 2025 3:02 pm ET1min read
TGTX--
The Golden Cross occurs when a short-term moving average crosses above a long-term moving average, typically signaling a buy signal. The Bullish Marubozu formation, characterized by a single candlestick with no wicks, suggests strong buying pressure, further reinforcing the bullish sentiment [2].
The current market dynamics are characterized by strong buying interest, which is likely to sustain the bullish momentum in the near future. This positive technical development comes amidst recent earnings reports that showed mixed performance, with analysts adjusting their ratings accordingly. Goldman Sachs, for instance, has resumed coverage of TGTX with a Neutral rating and a $37.00 price target [3].
Investors should monitor the stock closely for further price movements. While the recent signals are promising, it is essential to consider the broader market conditions and the company's fundamentals. TG Therapeutics Inc focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases, with a strong pipeline of investigational medicines [4].
References:
[1] https://www.investing.com/equities/tg-therapeutics-inc
[2] https://www.investing.com/equities/tg-therapeutics-inc
[3] https://www.investing.com/equities/tg-therapeutics-inc
[4] https://www.investing.com/equities/tg-therapeutics-inc
Tg Therapeutics's 15-minute chart has recently triggered a Golden Cross on the KDJ indicator, accompanied by a Bullish Marubozu formation on August 28, 2025 at 15:00. This signifies a shift in momentum towards the upside, with the potential for further price appreciation. The current market dynamics are characterized by strong buying interest, which is likely to sustain the bullish momentum in the near future.
On August 28, 2025, at 15:00, TG Therapeutics Inc (TGTX) stock experienced a significant technical shift. The 15-minute chart triggered a Golden Cross on the KDJ indicator, accompanied by a Bullish Marubozu formation. This combination of signals signifies a shift in momentum towards the upside, indicating potential for further price appreciation [1].The Golden Cross occurs when a short-term moving average crosses above a long-term moving average, typically signaling a buy signal. The Bullish Marubozu formation, characterized by a single candlestick with no wicks, suggests strong buying pressure, further reinforcing the bullish sentiment [2].
The current market dynamics are characterized by strong buying interest, which is likely to sustain the bullish momentum in the near future. This positive technical development comes amidst recent earnings reports that showed mixed performance, with analysts adjusting their ratings accordingly. Goldman Sachs, for instance, has resumed coverage of TGTX with a Neutral rating and a $37.00 price target [3].
Investors should monitor the stock closely for further price movements. While the recent signals are promising, it is essential to consider the broader market conditions and the company's fundamentals. TG Therapeutics Inc focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases, with a strong pipeline of investigational medicines [4].
References:
[1] https://www.investing.com/equities/tg-therapeutics-inc
[2] https://www.investing.com/equities/tg-therapeutics-inc
[3] https://www.investing.com/equities/tg-therapeutics-inc
[4] https://www.investing.com/equities/tg-therapeutics-inc
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet